Back to Search
KEVIN BOEHM, M.D.
M.D.
Family Medicine Physician
NPI: 1275746638IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
42507(CO)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2001
Research & Publications (20)
Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy.
PMID 19633050·Ann Oncol·2010
3-trial
Thermodynamic analysis of denaturant-induced unfolding of HodC69S protein supports a three-state mechanism.
PMID 18549245·Biochemistry·2008
8-other
Application of pressure-modulated differential scanning calorimetry to the determination of relaxation kinetics of multilamellar lipid vesicles.
PMID 16831505·Biophys Chem·2007
8-other
Pressure-modulated differential scanning calorimetry. An approach to the continuous, simultaneous determination of heat capacities and expansion coefficients.
PMID 16478087·Anal Chem·2006
8-other
Diagnosis and management of neurally mediated syncope and related conditions in adolescents.
PMID 11137899·J Adolesc Health·2001
6-review
Green tea (Camellia sinensis) for the prevention of cancer.
PMID 19588362·Cochrane Database Syst Rev·2009
1-meta
Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer.
PMID 19224848·J Clin Oncol·2009
3-trial
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
PMID 19204201·J Clin Oncol·2009
3-trial
Phase II trial of sunitinib for the therapy of progressive metastatic castration-refractory prostate cancer after previous docetaxel chemotherapy.
PMID 18824440·Clin Genitourin Cancer·2008
3-trial
Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.
PMID 19036692·Clin Colorectal Cancer·2008
3-trial
Cancer of the pancreas: are we making progress? A review of studies in the US Oncology Research Network.
PMID 18813198·Cancer Control·2008
6-review
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
PMID 18621615·Clin Breast Cancer·2008
3-trial
Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma.
PMID 18473121·Invest New Drugs·2008
3-trial
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.
PMID 17897959·Ann Oncol·2008
3-trial
Stability, unfolding, and structural changes of cofactor-free 1H-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase.
PMID 17371045·Biochemistry·2007
8-other
Systemic therapy for gastric cancer and adenocarcinoma of the gastroesophageal junction: present status and future directions.
PMID 17594189·Expert Opin Investig Drugs·2007
6-review
Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapy.
PMID 18272030·Clin Genitourin Cancer·2007
3-trial
Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer.
PMID 17026805·Clin Genitourin Cancer·2006
3-trial
Phase II study of low-dose docetaxel/estramustine in elderly patients or patients aged 18-74 years with hormone-refractory prostate cancer.
PMID 17239275·Clin Genitourin Cancer·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1044 S 88TH ST STE 2
LOUISVILLE, CO 80027 - Phone
- (303) 666-7119
Quick Facts
- NPI
- 1275746638
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile